drugset / Trial / NCT03571282
Safety and Effectiveness of Intravitreal Conbercept for Exudative Circumscribed Choroidal Haemangioma
NaSingle-groupOpen-labelTreatment
Summary
This prospective clinical trial aims to evaluate the safety and effectiveness study of intravitreal conbercept injection for exudative circumscribed choroidal haemangioma.
Timeline
- Start
- 2018-06-06
- Primary completion
- 2019-06-06
- Completion
- 2019-06-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Conbercept | Protein / enzyme biologic | — | Intravitreal |